Loading...
Continue your research
Related EMR software and healthcare technology resources.
No approved user rating is available here for Elekta – IMPAC Medical Systems Inc. This does not establish product quality or market adoption.
0 approved reviews. Verification is shown per review; no score is inferred from catalog features.
These are evaluation prompts, not findings from user reviews. Legacy sentiment summaries and pros-and-cons rankings are omitted pending claim-level source review.
Elekta IMPAC Medical Systems provides specialized oncology information systems designed primarily for radiation oncology departments, cancer centers, and comprehensive oncology practices. Originally founded as IMPAC Medical Systems in 1972 and acquired by Elekta in 2005, the company has established itself as a leading provider of radiation oncology software worldwide. The MOSAIQ platform represents Elekta's flagship oncology information system, offering an integrated suite for managing radiation oncology, medical oncology, and particle therapy workflows. The system is specifically engineered to handle the complex documentation requirements of cancer treatment, including treatment planning integration, linear accelerator connectivity, dose tracking, and regulatory compliance for radiation therapy protocols. MOSAIQ serves as both an oncology-specific EMR and a comprehensive oncology practice management system. The platform's primary differentiator is its deep integration with radiation therapy equipment and treatment planning systems. Unlike general ambulatory EMR systems that may offer oncology modules, IMPAC's solutions are purpose-built for the unique needs of radiation oncology workflows, including DICOM RT support, treatment verification, quality assurance documentation, and physics calculations. The system connects directly to treatment delivery devices, particularly Elekta's own linear accelerators and other radiation therapy equipment. Elekta IMPAC primarily targets medium to large oncology practices, hospital-based cancer centers, academic medical centers with radiation oncology departments, and comprehensive cancer treatment facilities. The deployment model typically involves on-premises enterprise installations, though cloud-hosted options have become available in recent years. Implementation complexity is significant due to the specialized nature of radiation oncology equipment integration. The system serves a global customer base with installations in over 60 countries, making it one of the most widely deployed radiation oncology information systems worldwide. Key strengths include strong treatment planning integration, comprehensive radiation therapy workflow support, multi-modality treatment tracking, and extensive quality assurance tools. The platform is designed to meet stringent radiation oncology regulatory requirements including those from the American College of Radiology and various international regulatory bodies. While IMPAC offers general ambulatory EMR capabilities for oncology practices, its core value proposition centers on radiation oncology departments requiring sophisticated treatment planning integration and device connectivity. The system competes primarily with Varian's ARIA oncology information system rather than traditional ambulatory EMR vendors.
Elekta – IMPAC Medical Systems Inc primarily serves the Physician practices, Outpatient clinics, Specialty practices, Multi-provider groups market segments.
Share your experience with Elekta – IMPAC Medical Systems Inc to help other practices evaluate it.
Write a ReviewPricing model: Current commercial model is a subscription for Elekta ONE oncology software solutions, with package selection and pricing handled by Elekta/account representatives. Packages include different feature sets and are tied to a purchased patient-volume band; later-year adjustment is described, but the subscription term, patient thresholds, and amounts are undisclosed. Current MOSAIQ is presented as the oncology information-system foundation/powered solution within Elekta ONE rather than as an openly priced standalone product.. Starting at See product pricing and terms.